- Investigator
- R. David Anderson
- Status
- Accepting Candidates
Research at a glance
Top areas of exploration
- Myocardial Infarction , 22 publications
- Myocardial Ischemia , 15 publications
- Coronary Artery Disease , 14 publications
- Coronary Circulation , 10 publications
Research activity
Active clinical trials
The purpose of this study is to assess if using the Impella® CP (or Impella® 2.5) device during high-risk PCI in patients with reduced left-sided heart function will result in an improvement in symptoms, heart function and health after a heart…
- Investigator
- R. David Anderson
- Status
- Accepting Candidates
- Ages
- 18 Years - 90 Years
- Sexes
- All
This is a prospective, multi-center, randomized, controlled, patient* and evaluator-blinded study comparing treatment with the CardiAMP cell therapy to a sham control treatment. A roll-in phase with a maximum of 10 subjects may occur.
- Investigator
- R. David Anderson
- Status
- Accepting Candidates
- Ages
- 21 Years - 90 Years
- Sexes
- All
My publications
Filter publications
115 publications
2024
CYP2C19 Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary Intervention
Journal of the American Heart Association
2024
Enhancing Frailty Assessments for Transcatheter Aortic Valve Replacement Patients Using Structured and Unstructured Data: Real-World Evidence Study
JMIR Aging
•2023
Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Patients Treated With P2Y12 Inhibitors
Journal of the American Heart Association
2023
EXACT Trial: Results of the Phase 1 Dose-Escalation Study
Circulation: Cardiovascular Interventions
2021
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease
New England Journal of Medicine